CompletedNot Applicable

Angioplasty of Left Main - lAriboisiere Registry

France125 participantsStarted 2007-01

Plain-language summary

In patients with unprotected left main disease (ULMD), angioplasty is emerging as an alternative technique. The investigators aimed to determine the rate of major cardiovascular events in patients treated by angioplasty for ULMD in a "real world" registry.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * stable or unstable angina and/or documented ischemia * 50% de novo ULMD referred for angioplasty Exclusion Criteria: * acute coronary syndrome with ST elevation, * cardiogenic shock or out of hospital cardiac arrest

What they're measuring

Major cardiovascular events (MACCE)

Timeframe: One year

Trial details

NCT IDNCT01725373

SponsorHopital Lariboisière

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2012-05

View on ClinicalTrials.gov More Coronary Artery Disease trials